The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) |
93.121, 93.279, 93.307, 93.399 |
PAR-18-847 |
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) |
93.113, 93.121, 93.279, 93.399 |
PAR-18-846 |
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) |
93.113, 93.121, 93.279, 93.399 |
PAR-18-845 |
Trafficking Victim Assistance Program-ACF regions 5, 6, 7, and 8 |
93.598 |
HHS-2018-ACF-IOAS-OTIP-ZV-1370 |
Trafficking Victim Assistance Program-ACF regions 1, 2, 3, and 4 |
93.598 |
HHS-2018-ACF-IOAS-OTIP-ZV-1369 |
Trafficking Victim Assistance Program-ACF regions 9 and 10 |
93.598 |
HHS-2018-ACF-IOAS-OTIP-ZV-1371 |
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) |
93.172 |
PAR-18-843 |
Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-18-025 |
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional) |
93.394 |
PAR-18-841 |
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required) |
93.855 |
RFA-AI-18-022 |
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |
PA-18-842 |
Limited Competition: Human Heredity and Health in Africa Consortium Biorepository (U24 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-020 |
Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-19-011 |
Northwest Coast Arts Development and Training |
15.945 |
NPS-DOIP18AP00110 |
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) |
93.865 |
PA-18-839 |
NEA The Citizens' Institute on Rural Design TM (CIRD), FY2019 |
45.024 |
NEAPS1803 |
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional) |
93.865 |
PA-18-838 |
Rural Housing Preservation Grant |
10.433 |
USDA-RD-HCFP-HPG-2018 |
NIA AD/ADRD Health Care Systems Research Collaboratory (U54 - Clinical Trial Required) |
93.866 |
RFA-AG-19-009 |
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed) |
93.393, 93.396 |
RFA-CA-18-025 |
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-19-015 |
High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-19-016 |
Data Management Supporting Hawaii and Pacific Islands Refuges |
15.678 |
F18AS00184 |
Service Area Competition |
93.224 |
HRSA-19-013 |
Notice of Funding Availability (NOFA) for the Fiscal Year (FY) 2018 Continuum of Care Program Competition |
14.267 |
FR-6200-N-25 |
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed) |
93.855 |
RFA-AI-18-026 |
Lead-Based Paint Hazard Reduction Program |
14.900 |
FR-6200-N-12 |
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
93.113, 93.121, 93.173, 93.242, 93.853, 93.865, 93.866, 93.867, 93.989 |
PAR-18-836 |
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) |
93.113, 93.173, 93.242, 93.853, 93.865, 93.866, 93.867, 93.989 |
PAR-18-835 |
Service Area Competition-Additional Areas (SAC-AA) - Chicago, IL and Toledo, OH |
93.224 |
HRSA-19-091 |
Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 - Clinical Trial Not Allowed) |
93.865 |
PAR-18-834 |
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
93.242 |
PAR-18-832 |
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
93.242 |
PAR-18-833 |
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) |
93.865 |
RFA-HD-19-015 |
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) |
93.393, 93.396, 93.865, 93.867 |
PAR-18-830 |
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed) |
93.865 |
PAR-18-831 |
Service Area Competition |
93.224 |
HRSA-19-012 |
Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional) |
93.855, 93.865 |
RFA-AI-18-023 |
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required) |
93.393, 93.394, 93.395, 93.399 |
RFA-CA-18-017 |
Jobs Plus Initiative |
14.895 |
FR-6200-N-14 |
Search Results 6841-6880 of 18315 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 [Next] |